Case 5-2017: A 19-year-old man with hematuria and a retroperitoneal mass

ML Blute Sr, JS Abramson, KC Cronin… - New England Journal …, 2017 - Mass Medical Soc
Case 5-2017: A 19-Year-Old Man with Hematuria and a Retroperitoneal Mass Page 1 n engl j
med 376;7 nejm.org February 16, 2017 684 The new england journal of medicine Presentation …

Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease

C Casper, DY Teltsch, D Robinson Jr… - British journal of …, 2015 - Wiley Online Library
Multicentric Castleman disease (MCD) is a rare lymphoproliferative disease. Little is known
about how patient clinical features and healthcare utilization varies by human …

局限性巨淋巴结增生的临床特征及治疗

肖峻, 陈凌武, 陈炜, 周林玉, 李晓飞, 陈羽, 丘少鹏 - 中华肿瘤杂志, 2012 - cqvip.com
目的探讨局限性巨淋巴结增生的临床特征及治疗方法, 以提高对该病的诊治水平.
方法回顾性分析20 例经手术切除的局限性巨淋巴结增生患者的临床, 病理, 影像学特点 …

Kaposi's sarcoma, biologics and small molecules: Navigating the complex interplay between host immunity and viral biology. A case series with focused review of the …

L Brambilla, CA Maronese, E Zelin… - Dermatologic …, 2022 - Wiley Online Library
The consequences of cytokine‐specific immune modulation in the development and course
of Kaposi's sarcoma (KS) are poorly understood. A retrospective chart review of patients …

[HTML][HTML] Biologic agents in the treatment of multicentric Castleman Disease

K Kapriniotis, S Lampridis, S Mitsos… - Turkish Thoracic …, 2018 - ncbi.nlm.nih.gov
Multicentric Castleman disease (MCD) causes an extensive range of systematic symptoms
and can be life-threatening if not treated promptly and appropriately. The pathophysiology of …

[HTML][HTML] Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood

L Lin, JY Lee, LD Kaplan, BJ Dezube… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose To determine the relative frequency with which Kaposi's sarcoma–associated
herpesvirus/HHV-8 (KSHV) DNA is detected in peripheral-blood mononuclear cells …

Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient

AB Law, G Ryan, S Lade, HM Prince - International journal of hematology, 2010 - Springer
1 Discussion Multicentric Castleman's disease is a lymphoproliferative disorder that occurs
frequently in immunosuppressed patients and also less commonly in immunocompetent …

Clinical management of HIV-associated hematologic malignancies

CCJ Wang, LD Kaplan - Expert Review of Hematology, 2016 - Taylor & Francis
ABSTRACT HIV is associated with an excess risk for lymphoid malignancies. Although the
risk of lymphoma has decreased in HIV-infected individuals in the era of effective …

[PDF][PDF] Treatment of multicentric Castleman's disease in HIV-1 infected and uninfected patients: a systematic review

C Rokx, BJ Rijnders, JA van Laar - Neth J Med, 2015 - njmonline.nl
ABSTRACT Background: Multicentric Castleman's disease (MCD) is frequently associated
with human-herpesvirus (HHV)-8, especially in human immunodeficiency virus (HIV)-1 co …

[HTML][HTML] Castleman's disease of the spleen

HJ Lee, HJ Jeon, SG Park, CY Park - World Journal of …, 2015 - ncbi.nlm.nih.gov
Castleman's disease (CD) is a rare lymphoproliferative disorder of unknown etiology.
Clinically, it occurs as a localized (unicentric) disease or as a systemic (multicentric) …